A-share CPO sector opened broadly lower; Cambridge Technology hit limit-down, Shenzhen Tech fell over 9%, and Dongshan Precision and HC Semitek also declined.

Guansheng Co. said at an investor-relations meeting its intelligent bionic joint-arm is still in the R&D/iteration phase and has not entered mass production; there are no orders and no revenue from the product and the company says it remains a long way from volume manufacture. The firm said the arm uses a biomimetic joint design with integrated universal-joint technology to reduce fore-/upper-arm vibration, lower inertia and raise end-load capacity. A hierarchical control architecture (central/local “big brain–small brain” fusion) means a single limb compute-unit failure won’t disable the whole system, and arms can perform emergency obstacle avoidance via local sensors if central command is lost. End effectors are quick-change (five-finger dexterous hand, three-finger gripper, electric screwdriver), and current go-to-market focus is biomedical labs and small-item sorting.

ECB President Lagarde said Europe is not in stagflation.